S. aureus | GenomeWeb

S. aureus

This Week in PNAS

In PNAS this week: ancient Aboriginal Australian mitochondrial genomes, metabolic dynamics of Staphylococcus aureus strains, and more.

This Week in PNAS

In PNAS this week: degenerative myopathy risk in corgis, genes influencing Vibrio parahaemolyticus fitness, and more.

Researchers in the UK have developed a faster way to gauge antibiotic resistance from bacterial genomes.

The service is the first fruit of an earlier collaboration signed between the companies, and BioMérieux plans to expand it to 10 other microbes over the next two years. 

Vela Diagnostics this week announced the CE-IVD launch of its Sentosa SA Direct MRSA/SA PCR test.

NEW YORK (GenomeWeb News) – Becton Dickinson today announced that it has received US Food and Drug Administration clearance to market its new assay for detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from nasal swabs.

DxNA, a privately owned St. George, Utah-based molecular diagnostics firm, will acquire privately held Flagstaff, Ariz.-based Pathogene for an undisclosed amount under an agreement inked by the companies this week.

NEW YORK (GenomeWeb News) – The US Department of Defense has granted investigators at the University of Washington and their partners $9.6 million to support the development of a paper-based molecular diagnostic testing system that could be used in remote regions and in homes around the world by

A flurry of recently published peer-reviewed papers has demonstrated the growing breadth and diversity of applications for Bio-Rad's QX100 Droplet Digital PCR system.

DxNA has acquired exclusive rights to run PathoGene's multiplexed Staphylococcus MRSA+ assay on DxNA's real-time PCR-based GeneStat platform, the companies said this week.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.